United Kingdom - English - myHealthbox

chiesi limited - salbutamol sulfate - modified release capsules, hard - 4.80mg - selective beta2 -adrenoceptor agonists for systemic use - continuous symptomatic treatment of asthma and other types of reversible obstructive airways disease

United Kingdom - English - myHealthbox

chiesi limited - salbutamol sulfate - modified release capsules, hard - 9.60mg - selective beta2 -adrenoceptor agonists for systemic use - continuous symptomatic treatment of asthma and other types of reversible obstructive airways disease

Ireland - English - HPRA (Health Products Regulatory Authority)

le vet beheer b.v. - clenbuterol hydrochloride - syrup - 25 microgram(s)/millilitre - clenbuterol - horses - respiratory tract preparations

Ireland - English - HPRA (Health Products Regulatory Authority)

glaxosmithkline (ireland) limited - salbutamol - concentrate for solution for infusion - 1 milligram(s)/millilitre - selective beta-2-adrenoreceptor agonists; salbutamol

Ireland - English - HPRA (Health Products Regulatory Authority)

glaxosmithkline (ireland) limited - salbutamol sulfate - oral solution - 2 mg/5ml - selective beta-2-adrenoreceptor agonists; salbutamol

Israel - English - Ministry of Health

glaxo smith kline (israel) ltd - salbutamol as sulfate - syrup - salbutamol as sulfate 2 mg / 5 ml - salbutamol - salbutamol - relief of bronchospasm in bronchial asthma of all types,chronic bronchitis,efmphysema.

Israel - English - Ministry of Health

glaxo smith kline (israel) ltd - salbutamol as sulfate - tablets - salbutamol as sulfate 2 mg - salbutamol - salbutamol - relief of bronchospasm in bronchial asthma of all types, chronic bronchitis, emphysema.

Malta - English - Medicines Authority

glaxo wellcome uk limited - salbutamol - syrup - salbutamol 2 mg/5ml - drugs for obstructive airway diseases

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

farmaclair - salbutamol (salbutamol sulfate) - syrup - 2mg/5ml

Ireland - English - HPRA (Health Products Regulatory Authority)

astrazeneca ab - terbutaline sulfate - solution for injection/infusion - 500 microgram(s)/millilitre - selective beta-2-adrenoreceptor agonists; terbutaline